标普生物科技LOF(161127)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
- |
- |
- |
- |
存出保证金 |
- |
- |
- |
- |
交易性金融资产 |
315,033,281.78 |
285,127,680.16 |
297,835,054.14 |
296,753,017.39 |
其中:股票投资 |
315,033,281.78 |
285,127,680.16 |
297,835,054.14 |
296,753,017.39 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
- |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
561,508.54 |
- |
- |
- |
其他资产 |
- |
- |
- |
- |
资产总计 |
335,093,387.24 |
306,732,520.78 |
317,396,888.76 |
317,815,159.83 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
640,454.53 |
- |
- |
- |
应付赎回款 |
502,579.47 |
210,079.11 |
200,350.42 |
1,108,557.54 |
应付管理人报酬 |
219,404.15 |
206,526.62 |
205,814.98 |
203,279.06 |
应付托管费 |
54,851.07 |
64,539.57 |
64,317.18 |
63,524.72 |
应付销售服务费 |
2,525.71 |
1,349.13 |
737.43 |
1,073.33 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
120,146.22 |
275,191.11 |
210,074.08 |
301,035.65 |
负债合计 |
1,539,961.15 |
757,685.54 |
681,294.09 |
1,677,470.30 |
所有者权益 |
实收基金 |
274,914,708.81 |
231,184,038.68 |
233,422,183.91 |
241,933,421.14 |
未分配利润 |
58,638,717.28 |
74,790,796.56 |
83,293,410.76 |
74,204,268.39 |
所有者权益合计 |
333,553,426.09 |
305,974,835.24 |
316,715,594.67 |
316,137,689.53 |
负债及所有者权益总计 |
335,093,387.24 |
306,732,520.78 |
317,396,888.76 |
317,815,159.83 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年